Ardea Biosciences (RDEA) Posts Q2 Loss of $0.49 Ex-Items, Misses Street Target

August 6, 2010 8:35 AM EDT
Ardea Biosciences, Inc. (Nasdaq: RDEA) reports Q2 EPS of $0.49, ex-items, versus the analyst estimate of ($0.12). Revenue for the quarter was $3.5 million, which compares to the estimate of $4.13 million.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Add Your Comment